WASHINGTON (MedPage Today) — The FDA has approved a new sublingual film formulation of the opioid dependence treatment combination buprenorphrine/naloxone (Suboxone). (Source: MedPage Today Public Health)
Opioid Dependence Drug Gets Okay for New Delivery Mode
Previous post: Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases.
